News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Monika Bickert will leave Meta for a teaching role at Harvard Law and stay through August to manage the transition.
  • Osisko reported about CAD 422.3 million in cash and nearly 4,000 ounces of gold sold from Tintic activities.
  • The company closed a CAD 82.5 million private placement and US$143.8 million prospectus offering and resumed Cariboo project work.
  • Former Nepal prime minister K.P. Sharma Oli was detained as a probe recommended prosecuting him over protests that killed 76 people.
  • India signaled willingness to accept a two-year extension of the WTO moratorium on e-commerce tariffs, easing ministerial negotiations.
  • Trump urged Saudi Arabia to join the Abraham Accords and extended his Iran strike deadline to April 6 pending Strait of Hormuz progress.

Latest Articles

RBC Capital Moves Thomson Reuters to Outperform, Sees AI as Growth Lever

RBC Capital Moves Thomson Reuters to Outperform, Sees AI as Growth Lever

RBC Capital upgraded Thomson Reuters (NASDAQ: TRI) from Sector Perform to Outperform and established a $126.00 price target, citing what the firm describes as an "asymmetric set-up" after a notable share price decline. The bank highlights the emergence of agentic artificial intelligence as a factor that complicates total addressable market and mark…

4basebio names Dr Amy Walker as CEO in management reshuffle

4basebio names Dr Amy Walker as CEO in management reshuffle

4basebio PLC has elevated its chief operating officer, Dr Amy Walker, to the role of chief executive officer. The move accompanies a reorganization in which outgoing CEO Dr Heikki Lanckriet will stay on the company board while separating the Hermes nanoparticle-based DNA delivery platform into a standalone, separately-funded therapeutics business. …

Goldman Sachs Lowers Clariant to Sell, Raises Price Target to CHF8.00

Goldman Sachs Lowers Clariant to Sell, Raises Price Target to CHF8.00

Goldman Sachs has cut Clariant AG's rating from Neutral to Sell while nudging its price target up to CHF8.00 from CHF7.50. The bank cites the company's relatively greater exposure to late-cycle pressures, particularly in its Catalyst segment, and forecasts subdued EBITDA growth through 2027. Market data shows the stock trading beneath its calculate…

Cisco Introduces Silicon One G300 to Accelerate AI Data Center Networking

Cisco Introduces Silicon One G300 to Accelerate AI Data Center Networking

Cisco unveiled the Silicon One G300 switch chip and an associated router designed to improve data movement across very large AI deployments. Built on TSMC's 3-nanometer process and slated to reach the market in the second half of the year, the G300 includes latency- and congestion-mitigation features Cisco calls "shock absorbers" and is claimed to …

Barclays Raises CEO Pay Package to £15 Million as Bonus Pool Expands

Barclays Raises CEO Pay Package to £15 Million as Bonus Pool Expands

Barclays has increased chief executive C.S. Venkatakrishnan’s total remuneration to 15 million pounds for 2025 from 11.6 million pounds a year earlier, driven by a rise in variable pay and bonuses. The lender cut the CEO’s fixed pay while raising variable compensation to 12.7 million pounds, and reported a 15% increase in its overall staff bonus po…

B. Riley Starts Coverage on Microbot Medical, Assigns Buy and $5 Target

B. Riley Starts Coverage on Microbot Medical, Assigns Buy and $5 Target

B. Riley has opened coverage of Microbot Medical (MBOT) with a Buy rating and a $5.00 price target, implying roughly 172% upside from the stock's $1.84 price. The initiation follows FDA 510(k) clearance and a limited U.S. commercial roll-out of the LIBERTY Endovascular Robotic System. The company has reported recent quarterly losses but holds more …

Arch Capital: Underwriting Discipline Looks Mispriced After the Pullback

Arch Capital: Underwriting Discipline Looks Mispriced After the Pullback

Arch Capital (ACGL) has pulled back into the mid-$90s on heavy volume and short-selling, but fundamentals - low leverage, strong free cash flow ($6.295B), and attractive valuation (PE ~8.6, P/B ~1.47) - argue for a tactical long. This trade idea lays out an entry at $96.03, a stop at $86.00 and a primary target of $110.00 over a 180-trading-day hor…

RBC Identifies Inditex and Next as Top Picks Amid European Retail Headwinds

RBC Identifies Inditex and Next as Top Picks Amid European Retail Headwinds

RBC Capital Markets has highlighted a pair of European retailers that, in its view, combine disciplined pricing with favorable earnings prospects. Inditex (ITX) is cited for maintaining stable pricing across product categories and protecting both volumes and margins through targeted price adjustments. Next (NXT) is favoured for its clear earnings v…